Read Time: 3 minutes

Huntsman Cancer Institute at the 香蕉视频 of Utah proudly announces that Anna Parks, MD, Huntsman Cancer Institute investigator, assistant professor in the and faculty member, has been awarded the . This prestigious career development award provides $150,000 in funding over 2鈥3 years, supporting promising early career hematologists dedicated to advancing the field through innovative research.
"I am delighted to congratulate Dr. Parks on receiving this award. This recognition is a testament to her exceptional dedication, innovative research, and unwavering commitment to advancing the field of hematology,鈥 says Ramiro Garzon, MD, chief of at Huntsman Cancer Institute and 香蕉视频 of Utah Health. 鈥淒r. Parks' contributions have already made a significant impact, and I am confident that her future work will continue to drive important advancements in our understanding and treatment of hematological malignancies.鈥
Parks specializes in non-malignant hematologic disorders, particularly thrombotic conditions. Her commitment to providing compassionate, individualized care underscores her dual dedication to treating disease and enhancing her patients鈥 quality of life. As a clinician and researcher, Parks seeks to bridge the gap between scientific discovery and patient care.
鈥淚t is an incredible honor to receive the ASH Scholar Award, following in the footsteps of so many amazing Huntsman Cancer Institute faculty members,鈥 Parks says. 鈥淚鈥檓 grateful to be able to continue our work that integrates the best of aging science, including a focus on quality of life and patients鈥 goals, with the best of hematology, including a mechanistic understanding of thrombosis. Thrombosis affects 900,000 Americans annually, and I鈥檓 grateful for the support from ASH to work to improve the quality of their care.鈥
鈥淚鈥檓 grateful to be able to continue our work that integrates the best of aging science, including a focus on quality of life and patients鈥 goals, with the best of hematology.鈥
Anna Parks, MD
Her research explores the intersection of aging and hematology, aiming to improve outcomes for older adults with blood disorders. Through her work, Parks addresses the unique challenges faced by this population, developing strategies to optimize treatment and care. Her research has previously garnered support from the and ASH, reinforcing her growing influence.
Beyond her research and clinical work, Parks is passionate about mentoring and teaching the next generation of hematology leaders. Her dedication to education ensures that future clinicians and researchers are equipped with the knowledge and skills needed to continue advancing the field.
鈥淒r. Parks' contributions have already made a significant impact, and I am confident that her future work will continue to drive important advancements in our understanding and treatment of hematological malignancies.鈥
Ramiro Garzon, MD

The ASH Junior Faculty Scholar Award is a testament to Parks' dedication, expertise, and potential to contribute to hematology significantly. Huntsman Cancer Institute and the 香蕉视频 of Utah celebrate her achievements and look forward to the continued impact of her work on patients and the broader medical community.
Media Contact
Heather Simonsen
Public Affairs Senior Manager
Huntsman Cancer Institute
801 581-3194
public.affairs@hci.utah.edu
About Huntsman Cancer Institute at the 香蕉视频 of Utah
Huntsman Cancer Institute at the is the National Cancer Institute-designated Comprehensive Cancer Center for Utah, Idaho, Montana, Nevada, and Wyoming. With a legacy of innovative cancer research, groundbreaking discoveries, and world-class patient care, we are transforming the way cancer is understood, prevented, diagnosed, treated, and survived. Huntsman Cancer Institute focuses on delivering the most advanced cancer healing and prevention through scientific breakthroughs and cutting-edge technology to advance cancer treatments of the future beyond the standard of care today. We have more than 300 open clinical trials and 250 research teams studying cancer. More genes for inherited cancers have been discovered at Huntsman Cancer Institute than at any other cancer center. Our scientists are world-renowned for understanding how cancer begins and using that knowledge to develop innovative approaches to treat each patient鈥檚 unique disease. Huntsman Cancer Institute was founded by Jon M. and Karen Huntsman.